BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 23, 2014
View Archived Issues
Determination of the origin of bacterial lung infections in animal models of cystic fibrosis
Read More
Safety, immunogenicity and efficacy of DCVAC/PCa vaccine in recurrent prostate cancer
Read More
CRLX-522 leads to reduction of tumor growth in vivo
Read More
Novel PI3K-p110beta/delta inhibitor demonstrates potent antitumor efficacy in vivo
Read More
Novel cancer vaccine combined with cyclophosphamide shows potential in a phase I trial
Read More
NGM-282 shows promise in early clinical and preclinical studies
Read More
Dicerna drug is first Dicer-substrate siRNA to enter clinical trials
Read More
Alethia develops antibody-drug conjugate targeting KAAG1 for cancer
Read More
AbbVie submits NDA to FDA for all-oral, interferon-free therapy for HCV
Read More
NIH to support phase II trial of 3K3A-APC in stroke
Read More
Sentinel Oncology and Oncothyreon to develop and commercialize Chk1 inhibitors
Read More
Karyopharm initiates pediatric phase I trial of selinexor
Read More
Evoke Pharma begins phase III trial of EVK-001 for diabetic gastroparesis
Read More
New PKCiota inhibitors for cancer disclosed by Cancer Research Technology and Cephalon
Read More
Adcetris now available in Japan for Hodgkin's lymphoma or anaplastic large cell lymphoma
Read More
Japanese scientists present novel glucokinase activators
Read More
FDA accepts refiling of cobicistat and elvitegravir NDAs for HIV
Read More
Incruse Ellipta approved in Canada for COPD
Read More
Merck & Co. synthesizes novel GPR119 receptor agonists
Read More
Merck KGaA designs new vanin-1 inhibitors for inflammatory disorders
Read More
Revance Therapeutics reports data from phase I/II study of RT-002
Read More
Cubist Pharmaceuticals submits NDA to FDA for ceftolozane/tazobactam
Read More
Biogen Idec licenses Amunix's Factor VIII product
Read More
Aastrom Biosciences to acquire Sanofi's Cell Therapy and Regenerative Medicine business
Read More
GlaxoSmithKline and Novartis make major restructuring deal
Read More
FDA advisory committee recommends against approval of MoxDuo
Read More